A detailed history of Caption Management, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Caption Management, LLC holds 42,500 shares of BMRN stock, worth $2.7 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
42,500
Previous 47,700 10.9%
Holding current value
$2.7 Million
Previous $3.93 Million 23.94%
% of portfolio
0.05%
Previous 0.06%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$69.02 - $93.84 $1.88 Million - $2.56 Million
27,300 New
27,300 $1.92 Million
Q1 2024

May 15, 2024

BUY
$83.81 - $99.0 $808,682 - $955,251
9,649 Added 72.66%
22,929 $2 Million
Q4 2023

Feb 14, 2024

BUY
$76.22 - $98.51 $1.01 Million - $1.31 Million
13,280 New
13,280 $1.28 Million
Q2 2023

Aug 14, 2023

BUY
$86.68 - $100.3 $7.27 Million - $8.41 Million
83,872 Added 279.57%
113,872 $9.87 Million
Q1 2023

May 15, 2023

BUY
$87.74 - $117.27 $2.63 Million - $3.52 Million
30,000 New
30,000 $2.92 Million
Q2 2022

Aug 15, 2022

BUY
$71.48 - $86.85 $220,873 - $268,366
3,090 Added 18.84%
19,495 $1.62 Million
Q1 2022

May 13, 2022

BUY
$74.28 - $92.69 $1.22 Million - $1.52 Million
16,405 New
16,405 $1.26 Million
Q2 2021

Aug 16, 2021

SELL
$75.51 - $84.79 $1.92 Million - $2.15 Million
-25,399 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$74.73 - $90.69 $1.87 Million - $2.27 Million
24,997 Added 6218.16%
25,399 $1.92 Million
Q4 2020

Feb 16, 2021

SELL
$72.61 - $90.2 $2.17 Million - $2.7 Million
-29,898 Reduced 98.67%
402 $35,000
Q3 2020

Nov 16, 2020

SELL
$71.87 - $131.03 $2.64 Million - $4.81 Million
-36,688 Reduced 54.77%
30,300 $2.31 Million
Q2 2020

Aug 14, 2020

BUY
$79.55 - $124.22 $5.01 Million - $7.82 Million
62,988 Added 1574.7%
66,988 $8.26 Million
Q3 2019

Nov 14, 2019

SELL
$67.4 - $85.11 $842,500 - $1.06 Million
-12,500 Reduced 75.76%
4,000 $269,000
Q2 2019

Aug 13, 2019

SELL
$80.35 - $93.9 $490,134 - $572,790
-6,100 Reduced 26.99%
16,500 $1.41 Million
Q1 2019

May 14, 2019

SELL
$84.2 - $98.62 $202,080 - $236,688
-2,400 Reduced 9.6%
22,600 $2.01 Million
Q4 2017

Feb 14, 2018

BUY
$80.76 - $95.13 $2.02 Million - $2.38 Million
25,000
25,000 $2.23 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $11.8B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.